New drug SV001 aims to slow lung scarring in IPF patients
NCT ID NCT07121413
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug, SV001, in 48 adults with idiopathic pulmonary fibrosis (IPF), a disease that causes lung scarring and makes breathing hard. The main goal is to check if SV001 is safe and how the body processes it. Participants will receive either SV001 or a placebo, and researchers will monitor side effects and drug levels in the blood.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS (IPF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dongfang Hospital Affiliated to Tongji University
RECRUITINGShanghai, China
-
General Hospital of Tianjin Medical University
RECRUITINGTianjin, China
-
Hangzhou First People's Hospital
RECRUITINGHangzhou, China
-
Henan Provincial People's Hospital
RECRUITINGZhengzhou, China
-
Huadong Hospital Affiliated to Fudan University
RECRUITINGShanghai, China
-
Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School
RECRUITINGNanjing, China
-
Shanghai Pulmonary Hospital
RECRUITINGShanghai, China
-
Sichuan Provincial People's Hospital
RECRUITINGChengdu, China
-
The Affiliated Hospital of Inner Mongolia Medical University
RECRUITINGNeimeng, China
-
The Affiliated Hospital of Xuzhou Medical University
RECRUITINGXuzhou, China
-
The First Affiliated Hospital of Guangzhou Medical University
RECRUITINGGuangzhou, China
-
The First Affiliated Hospital of Nanchang University
RECRUITINGNanchang, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new daily pill slow lung scarring in IPF?
- Which finger or earlobe? a study tests the best spot for oxygen monitoring in lung disease
- Can a new drug slow lung scarring in IPF?
- Blood tests could unlock early clues for three major lung diseases
- AI could uncover hidden lung disease in routine chest X-Rays
- Inhaled drug could offer new hope for lung scarring disease